143 related articles for article (PubMed ID: 10605379)
1. Synthesis and calcium channel antagonist activity of dialkyl 1,4-dihydro-2,6-dimethyl-4-[4-(1-methoxycarbonyl-1,4-dihydropyridyl)]-3 ,5- pyridinedicarboxylates.
Ramesh M; Matowe WC; Wolowyk MW; Knaus EE
Arch Pharm (Weinheim); 1999 Nov; 332(11):385-8. PubMed ID: 10605379
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and calcium channel antagonist activity of dialkyl 1,4-dihydro-2,6-dimethyl-4-[3-(1-methoxy-carbonyl-4-substituted-1,4- dihydro-pyridyl)]-3,5-pyridinedicarboxylates.
Ramesh M; Matowe WC; Knaus EE; Wolowyk MW
Drug Des Discov; 1992 Jul; 8(4):313-23. PubMed ID: 1445996
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and smooth muscle calcium channel effects of dialkyl 1,4-dihydro-2,6-dimethyl-4-aryl-3,5-pyridinedicarboxylates containing a nitrone moiety in the 4-aryl substituent.
Anana RD; Ng H; Howlett SE; Knaus EE
Arch Pharm (Weinheim); 1997 Mar; 330(3):53-8. PubMed ID: 9167447
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and calcium channel-modulating effects of alkyl (or cycloalkyl) 1,4-dihydro-2,6-dimethyl-3-nitro-4-pyridyl-5-pyridinecarboxylate racemates and enantiomers.
Ramesh M; Matowe WC; Akula MR; Vo D; Dagnino L; Li-Kwong-Ken MC; Wolowyk MW; Knaus EE
J Med Chem; 1998 Feb; 41(4):509-14. PubMed ID: 9484501
[TBL] [Abstract][Full Text] [Related]
5. Hantzsch 1,4-dihydropyridines containing a diazen-1-ium-1,2-diolate nitric oxide donor moiety to study calcium channel antagonist structure-activity relationships and nitric oxide release.
Nguyen JT; Velázquez CA; Knaus EE
Bioorg Med Chem; 2005 Mar; 13(5):1725-38. PubMed ID: 15698790
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and calcium channel antagonist activity of dialkyl 1,4-dihydro-2,6-dimethyl-4-(pyridinyl)-3,5-pyridinedicarboxylates.
Dagnino L; Li-Kwong-Ken MC; Wolowyk MW; Wynn H; Triggle CR; Knaus EE
J Med Chem; 1986 Dec; 29(12):2524-9. PubMed ID: 3783612
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and calcium channel antagonist activity of new 1,4-dihydropyridine derivatives containing dichloroimidazolyl substituents.
Amini M; Golabchifar AA; Dehpour AR; Pirali HM; Shafiee A
Arzneimittelforschung; 2002; 52(1):21-6. PubMed ID: 11838270
[TBL] [Abstract][Full Text] [Related]
8. Design and synthesis of new 1,4-dihydropyridines containing 4(5)-chloro-5(4)-imidazolyl substituent as a novel calcium channel blocker.
Iman M; Davood A; Nematollahi AR; Dehpoor AR; Shafiee A
Arch Pharm Res; 2011 Sep; 34(9):1417-26. PubMed ID: 21975802
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and calcium channel antagonist activity of 3-arylmethyl 5-isopropyl 1,4-dihydro-2,6-dimethyl-4-(pyridyl)-3,5-pyridinedicarboxylates.
Akula MR; Matowe WC; Wolowyk MW; Knaus EE
Pharm Res; 1990 Sep; 7(9):919-22. PubMed ID: 2235890
[TBL] [Abstract][Full Text] [Related]
10. Synthesis, QSAR and calcium channel antagonist activity of new 1,4-dihydropyridine derivatives containing 1-methyl-4,5-dichloroimidazolyl substituents.
Hosseini M; Miri R; Amini M; Mirkhani H; Hemmateenejad B; Ghodsi S; Alipour E; Shafiee A
Arch Pharm (Weinheim); 2007 Oct; 340(10):549-56. PubMed ID: 17849444
[TBL] [Abstract][Full Text] [Related]
11. Synthesis, study of 3D structures, and pharmacological activities of lipophilic nitroimidazolyl-1,4-dihydropyridines as calcium channel antagonist.
Miri R; Javidnia K; Sarkarzadeh H; Hemmateenejad B
Bioorg Med Chem; 2006 Jul; 14(14):4842-9. PubMed ID: 16603367
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and calcium channel antagonist activity of nifedipine analogues containing 1,2-dihydropyridyl in place of the 1,4-dihydropyridyl moiety.
Soboleski DA; Li-Kwong-Ken MC; Wynn H; Triggle CR; Wolowyk MW; Knaus EE
Drug Des Deliv; 1988 Feb; 2(3):177-89. PubMed ID: 2855573
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and calcium channel antagonist activity of nifedipine analogues containing 1-oxido-2-pyridyl in place of the 2-nitrophenyl moiety.
Ramesh M; Matowe WC; Wolowyk MW; Knaus EE
Drug Des Deliv; 1988 Dec; 3(4):337-41. PubMed ID: 3255335
[TBL] [Abstract][Full Text] [Related]
14. Synthesis, rotamer orientation, and calcium channel modulation activities of alkyl and 2-phenethyl 1,4-dihydro-2,6-dimethyl-3-nitro-4-(3- or 6-substituted-2-pyridyl)-5-pyridinecarboxylates.
Iqbal N; Akula MR; Vo D; Matowe WC; McEwen CA; Wolowyk MW; Knaus EE
J Med Chem; 1998 May; 41(11):1827-37. PubMed ID: 9599233
[TBL] [Abstract][Full Text] [Related]
15. Design, synthesis, and calcium channel antagonist activity of new 1,4-dihydropyridines containing 4-(5)-chloro-2-ethyl-5-(4)-imidazolyl substituent.
Davood A; Mansouri N; Rerza Dehpour A; Shafaroudi H; Alipour E; Shafiee A
Arch Pharm (Weinheim); 2006 Jun; 339(6):299-304. PubMed ID: 16649160
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and calcium channel antagonist activity of dialkyl 4- (dihydropyridinyl)-1,4-dihydro-2,6-dimethyl-3,5-pyridinecarboxylates.
Dagnino L; Li-Kwong-Ken MC; Wynn H; Wolowyk MW; Triggle CR; Knaus EE
J Med Chem; 1987 Apr; 30(4):640-6. PubMed ID: 3560157
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and calcium antagonist activity of 1,4-dihydropyridines containing phenylaminoimidazolyl substituents.
Zarghi A; Sadeghi H; Fassihi A; Faizi M; Shafiee A
Farmaco; 2003 Nov; 58(11):1077-81. PubMed ID: 14572858
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and calcium antagonist activity of new 1,4-dihydropyridines containing nitrobenzylimidazolyl substituent in guinea-pig ileal smooth muscle.
Zarghi A; Derakhshandeh K; Roshanzamir F; Jorjani M; Rastegar H; Varmazyari M; Shafiee A
Boll Chim Farm; 2002; 141(1):15-20. PubMed ID: 12064052
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and calcium channel antagonist activity of new 1,4-dihydropyridine derivatives containing lipophilic 4-imidazolyl substituents.
Navidpour L; Miri R; Shafiee A
Arzneimittelforschung; 2004; 54(9):499-504. PubMed ID: 15500195
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and smooth muscle calcium channel antagonist effects of dialkyl 1,4-dihydro-2,6-dimethyl-4-aryl-3,5-pyridinedicarboxylates containing a nitrooxy or nitrophenyl moiety in the 3-alkyl ester substituent.
Iqbal N; Knaus EE
Arch Pharm (Weinheim); 1996 Jan; 329(1):23-6. PubMed ID: 8687280
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
